The march of IBM's Watson into biopharma R&D is continuing apace. Icon and Teva are the latest companies to ink deals to access the computer system, giving them new ways to match patients to clinical trials and create disease models.
IBM's Jeopardy-winning Watson had a busy day thanks to the opening of the new IBM Watson Health global HQ in Cambridge, MA. As is often the case, the ribbon cutting was accompanied by a plethora of newly announced customers and boasts about new capabilities.
Cloud computing courtesy of IBM has opened up shop in the heart of the Cambridge, MA, biotech hub today, bringing with it some key industry partnerships and a familiar tech manifesto aimed at commanding a big industry audience.
IBM has inked an agreement to buy Merge Healthcare for $1 billion. The acquisition would move its Watson computer system beyond natural language and into medical images, a field in which IBM thinks its computing power can improve the detection of changes and anomalies.
IBM's Jeopardy-winning Watson is known for its natural language abilities, but it will soon read medical images too, thanks to the company's planned acquisition of Chicago's Merge Healthcare for $1 billion.
IBM has continued its push into healthcare and research by striking deals with electronic health record software provider Epic, Mayo Clinic and 14 cancer institutes.
IBM is unleashing Watson on healthcare. The tech heavyweight's brand-new healthcare business unit says it will team up with 14 top cancer centers to turn genetic data into personalized patient treatments.
IBM is rolling out at an enhanced, cancer-fighting version of its Jeopardy-winning supercomputer Watson at more than a dozen hospitals across the U.S. The move demonstrates the advent of Big Data, cognitive technology and personalized medicine in healthcare.
IBM is unleashing Watson on healthcare. Fresh off a triad of big-name deals--Apple, Medtronic and Johnson & Johnson--the tech giant's brand-new healthcare business unit says it will work with 14 top cancer centers to turn genetic data into personalized patient treatments.
Apple just gained a powerful ally in its push to make ResearchKit a core component of the health research toolkit. The Silicon Valley tech giant has tapped IBM for access to Watson, the data-mining and predictive analytics capabilities of which will be applied to health research.